Literature DB >> 25691255

[Researcher of the month].

Anastasia Meshcheryakova.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25691255     DOI： 10.1007/s00508-015-0763-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  7 in total

1.  Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma.

Authors:  Astrid Slany; Verena Haudek-Prinz; Anastasia Meshcheryakova; Andrea Bileck; Wolfgang Lamm; Christoph Zielinski; Christopher Gerner; Johannes Drach
Journal:  J Proteome Res       Date:  2013-12-02       Impact factor: 4.466

2.  Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts.

Authors:  Verena Paulitschke; Walter Berger; Philipp Paulitschke; Elisabeth Hofstätter; Bernhard Knapp; Ruth Dingelmaier-Hovorka; Dagmar Födinger; Walter Jäger; Thomas Szekeres; Anastasia Meshcheryakova; Andrea Bileck; Christine Pirker; Hubert Pehamberger; Christopher Gerner; Rainer Kunstfeld
Journal:  Mol Cancer Ther       Date:  2015-01-22       Impact factor: 6.261

Review 3.  Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer.

Authors:  Diana Mechtcheriakova; Martin Svoboda; Anastasia Meshcheryakova; Erika Jensen-Jarolim
Journal:  Cancer Immunol Immunother       Date:  2012-04-19       Impact factor: 6.968

4.  Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling.

Authors:  Astrid Slany; Anastasia Meshcheryakova; Agnes Beer; Hendrik Jan Ankersmit; Verena Paulitschke; Christopher Gerner
Journal:  Clin Proteomics       Date:  2014-11-21       Impact factor: 3.988

5.  B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer.

Authors:  Anastasia Meshcheryakova; Dietmar Tamandl; Erika Bajna; Judith Stift; Martina Mittlboeck; Martin Svoboda; Denise Heiden; Stefan Stremitzer; Erika Jensen-Jarolim; Thomas Grünberger; Michael Bergmann; Diana Mechtcheriakova
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

6.  Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.

Authors:  René Köffel; Anastasia Meshcheryakova; Joanna Warszawska; Annika Hennig; Karin Wagner; Almut Jörgl; Daniela Gubi; Doris Moser; Anastasiya Hladik; Ulrike Hoffmann; Michael B Fischer; Wim van den Berg; Marije Koenders; Clemens Scheinecker; Bernhard Gesslbauer; Sylvia Knapp; Herbert Strobl
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

7.  AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.

Authors:  Martin Svoboda; Anastasia Meshcheryakova; Georg Heinze; Markus Jaritz; Dietmar Pils; Dan Cacsire Castillo-Tong; Gudrun Hager; Theresia Thalhammer; Erika Jensen-Jarolim; Peter Birner; Ioana Braicu; Jalid Sehouli; Sandrina Lambrechts; Ignace Vergote; Sven Mahner; Philip Zimmermann; Robert Zeillinger; Diana Mechtcheriakova
Journal:  BMC Genomics       Date:  2016-08-16       Impact factor: 3.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.